SUDEEP PHARMA LIMITED Share Price

₹ 1,107.20

+₹38.90 (3.64%)
1D
Last updated 02 Nov, 2026, 15:52 IST
NSE: SUDEEPPHRM
|
Chemicals

SUDEEP PHARMA LIMITED Share Price Today

As of 2 Nov 2026, SUDEEP PHARMA LIMITED share price is ₹1,107.20. The stock opened at ₹1,075.00, compared to its previous close of ₹1,068.30. During today's trading session, SUDEEP PHARMA LIMITED share price moved in the range of ₹1,051.70 to ₹1,114.00, with an average price of ₹1,082.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹524.05 and a high of ₹1,378.00. On the performance front, SUDEEP PHARMA LIMITED share price has increased by 50.99% over the last six months and is up 38.00% on a year-on-year basis.

Share price over the last 1 day rose from 1061.40 to 1109.50, ranging between 1055.10 and 1110.10.
₹1,051.70
3.64% up today
₹1,114.00
1D LOW
1D HIGH

SUDEEP PHARMA LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 30.83% QoQ
Latest Earning
Net Profit TrendUp by 27.64% QoQ
Latest Earning
Revenue TrendUp by 23.80% QoQ
Stock Performance
OutperformingBeat Nifty by 26.71 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 34.84%
Shareholding Pattern
FIIFII increased stake by 61.66%
SUDEEP PHARMA LIMITED stock performance
Open₹1,075.00
High₹1,114.00
Low₹1,051.70
Prev. close₹1,068.30
SUDEEP PHARMA LIMITED trading activity
Volume99,061
Average traded price₹1,090.81
Last traded time03:52:54 02 Nov
Last traded quantity5
Circuit
L
H
₹961.50
₹1,175.10
52-week
L
H
₹524.05
₹1,378.00
Mkt Cap Cr
12,048.23
P/E
63.87
P/B
12.59
ROA
14.2%
ROE
19.67%
ROCE
21.94%
Quick Ratio
2.02
EV/EBITDA
44.08

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Sudeep Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sudeep Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Sudeep Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Pidilite Industries1,48,706.8654.7213.2616.75%23.94%31.93%1.936.42
SRF69,481.9830.444.548.83%14.92%14.86%0.6818.48
Linde India48,171.6988.1611.299.41%12.87%17.16%0.7648.78
Gujarat Fluorochemicals46,693.9477.825.975.05%7.13%8.93%0.9735.15
Navin Fluorine44,522.3548.899.9813.33%20.41%22.03%2.1931.05
Godrej Industries30,491.7613.82.731.75%11.1%9.34%0.3512.06
Himadri Speciality Chemicals25,715.6229.935.0112.32%16.65%19.3%1.6720.28
Aether Industries21,507.9686.298.296.92%9.61%10.65%0.9651.82
Deepak Nitrite20,724.9219.513.210.83%16.4%18.59%1.7312.55
Castrol India18,595.5018.7510.0646.22%46.94%71.77%1.2812.07

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SUDEEP PHARMA LIMITED Company Background

ISIN
INE0QPI01025
Sector Market Cap
₹ 12,048.23 Cr

Sudeep Pharma Private Limited is an India-based manufacturing pharmaceutical and nutraceutical products company. The Company is engaged in business of manufacturing and selling pharmaceutical and food, nutrition and specialty ingredients and intermediaries, used by pharmaceutical, food and nutrition industries globally. The Company a wide range of products, including mineral salts such as calcium salts, zinc salts, iron salts, potassium salts, magnesium salts, sodium salts, simethicone salts and copper salts. It offers products to a wide range of markets, which includes pharmaceuticals, dietary health, infant nutrition, beverage, dairy products, bakery products, confectionery, and staple food markets. Its subsidiaries include Sudeep Nutrition Private Limited, Sudeep Pharma USA Inc., Sudeep Pharma B.V., and Sudeep Advanced Materials Private Limited.

SUDEEP PHARMA LIMITED Financial Highlights

  • Revenue: SUDEEP PHARMA LIMITED reported revenue of ₹670.85 crore in FY26 vs ₹511.33 crore in FY25. It showed an increase of 31.20% on a yearly basis.
  • Operating Profit: SUDEEP PHARMA LIMITED reported an operating profit of ₹228.07 crore in FY26 vs ₹182.85 crore in FY25. It showed an increase of 24.73% on a year-on-year basis.
  • Net Profit: SUDEEP PHARMA LIMITED reported a net profit of ₹174.28 crore in FY26 vs ₹138.73 crore in FY25. It showed an increase of 25.63% on a yearly basis.

SUDEEP PHARMA LIMITED Quarterly Result Highlights

  • SUDEEP PHARMA LIMITED reported revenue of ₹202.68 crore in Sep 2026, compared with ₹163.72 crore in Jun 2026, representing an increase of 23.80% on a quarter-on-quarter (QoQ) basis.
  • SUDEEP PHARMA LIMITED reported an operating profit of ₹71.03 crore in Sep 2026, compared with ₹54.29 crore in Jun 2026, representing an increase of 30.83% on a quarter-on-quarter (QoQ) basis.
  • SUDEEP PHARMA LIMITED reported a profit of ₹51.81 crore in Sep 2026, compared with ₹40.59 crore in Jun 2026, reflecting an increase of 27.64% on a QoQ basis.
  • The earnings per share (EPS) of SUDEEP PHARMA LIMITED stood at ₹15.50 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
76.15%
FII
2.93%
Other DII
6.63%
Retail and other
6.87%
Mutual funds
7.43%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.67%
Mar 20261.55%
Jun 20261.81%
Sep 20262.93%

SUDEEP PHARMA LIMITED Investment Returns

1 day
-5.47%
1 week
+10.57%
1 month
-11.40%
1 year
+38.00%
3 years
+38.00%
5 years
+38.00%

SUDEEP PHARMA LIMITED Share Price History

SUDEEP PHARMA LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹1,140.00 / ₹1,068.30
-5.47%
29 Oct 26
₹1,138.60 / ₹1,130.10
+0.99%
28 Oct 26
₹1,030.00 / ₹1,119.00
+9.45%
27 Oct 26
₹990.00 / ₹1,022.40
+4.01%
Show more

SUDEEP PHARMA LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹642.26₹502.00₹459.28₹428.74
Other Income₹28.59₹9.33₹6.10₹9.52
Total Revenue₹670.84₹511.33₹465.38₹438.26
Total Expenses₹442.77₹328.48₹290.56₹352.28
Profit Before Tax₹228.07₹182.85₹174.82₹85.98
Tax₹53.79₹44.12₹41.63₹23.66
Profit After Tax₹174.28₹138.73₹133.19₹62.32
EPS - Basic₹15.50₹12.79₹12.28₹5.74
EPS - Diluted₹15.50₹12.79₹12.28₹5.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹228.07₹182.85₹174.82₹85.98
Income before WC changes₹237.09₹198.30₹188.28₹103.89
Change in Assets-₹109.37-₹112.50-₹44.91-₹45.64
Change in Liabilities-₹2.70₹3.48-₹32.94₹12.57
Change in WC-₹112.07-₹109.02-₹77.85-₹33.07
Cash flow from Operations₹69.55₹48.73₹65.69₹48.40
Cash flow from Investing-₹330.93-₹78.76-₹49.28-₹50.02
Cash flow from Financing₹247.29₹52.70-₹12.74-₹9.78
Total Cash Flow-₹14.09₹22.67₹3.67-₹11.40
Cash (Start of the year)₹36.81₹13.98₹10.30₹21.47
Cash (End of the year)₹26.74₹36.81₹13.98₹10.30

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹550.91₹293.05₹238.50₹190.10
Current Assets₹623.97₹424.12₹275.37₹230.02
Total Assets₹1,174.88₹717.17₹513.87₹420.11
Current Liabilities₹201.96₹174.76₹137.22₹170.83
Net Current Asset₹422.00₹249.36₹138.14₹59.19
Non-Current Liabilities₹74.82₹49.32₹20.61₹26.00
Equity Capital₹898.09₹493.09₹356.03₹223.29
Total Equity & Liabilities₹1,174.88₹717.17₹513.87₹420.11

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹338.51₹356.73₹343.76₹404.00
Other Income₹38.50₹8.38₹8.20₹11.18
Total Revenue₹377.01₹365.11₹351.96₹415.17
Total Expenses₹231.91₹235.70₹219.65₹324.40
Profit Before Tax₹145.10₹129.41₹132.31₹90.77
Tax₹37.52₹33.66₹34.23₹23.60
Profit After Tax₹107.58₹95.75₹98.08₹67.17
EPS - Basic₹9.65₹8.82₹9.04₹476.69
EPS - Diluted₹9.65₹8.82₹9.04₹476.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹145.10₹129.41₹132.31₹90.77
Income before WC changes₹130.32₹138.37₹140.70₹103.31
Change in Assets-₹1.46-₹44.10₹6.91-₹54.18
Change in Liabilities₹5.15-₹5.44-₹52.33₹14.97
Change in WC₹3.70-₹49.54-₹45.42-₹39.22
Cash flow from Operations₹96.02₹59.15₹59.05₹42.31
Cash flow from Investing-₹366.68-₹91.59-₹40.67-₹40.71
Cash flow from Financing₹242.50₹54.20-₹16.14-₹10.11
Total Cash Flow-₹28.16₹21.75₹2.24-₹8.52
Cash (Start of the year)₹30.35₹8.59₹6.35₹14.87
Cash (End of the year)₹2.18₹30.35₹8.59₹6.35

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹515.83₹291.08₹219.85₹180.17
Current Assets₹457.95₹313.02₹230.75₹235.85
Total Assets₹973.78₹604.10₹450.60₹416.03
Current Liabilities₹145.07₹130.82₹104.51₹163.71
Net Current Asset₹312.88₹182.20₹126.24₹72.15
Non-Current Liabilities₹42.70₹43.16₹11.49₹15.44
Equity Capital₹786.01₹430.12₹334.60₹236.88
Total Equity & Liabilities₹973.78₹604.10₹450.60₹416.03
* All values are in INR Crore
SUDEEP PHARMA LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
531107.200
0000
0000
0000
0000
Total bid quantity53
Total ask quantity0
SUDEEP PHARMA LIMITED technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
49.32
Neutral
ATR (14)
62.76
Neutral
STOCH(9,6)
61.57
Neutral
STOCH RSI (14)
67.99
Neutral
ADX(9)
33.7
Bearish
UO(9)
61.3
Neutral
ROC(12)
5.54
Bullish
WillR(14)
-38.43
Neutral
Period
Simple value
Exponential vaue
5D
1064.56
1068.03
10D
1022.66
1052.05
20D
1059.39
1063.91
50D
1135.89
1073.07
100D
1007.37
1010.24
Volume trend — traded volume by day
2 Nov0L
30 Oct2L
29 Oct10L
28 Oct8L
27 Oct1L
26 Oct2L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SUDEEP PHARMA LIMITED
Chemicals
Add Stock
Add Another

SUDEEP PHARMA LIMITED Returns Calculator

Ex-date: 23 Jul 2026

SUDEEP PHARMA LIMITED Latest News

2 months ago
IPO buzz returns: NIFTY IPO index gains 5% in August; Dhoot Transmission, Milky Mist, Xtranet Technologies among top gainers
Showing news item 1 of 1

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

SUDEEP PHARMA LIMITED Share Price FAQs

Please be aware that SUDEEP PHARMA LIMITED stock prices are subject to continuous fluctuations due to various factors.